ArticleEJNMMI research2020

18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy.

Gaurav Malviya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.